¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2022-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2022-09-03
±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : ÀüÁÖ ÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ, ¼¼¹Ì³ª½Ç  
±³À°ÁÖÁ¦ : 2022³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ (ÀÌ»çÀåÁ¦)  
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 070-4888-5731  
À̸ÞÀÏ : ksbtp.svc@gmail.com      
±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : Àü¶óºÏµµ
±³À°½Ã°£ : 12 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï-Àü¹®ÀÇ 40,000¿ø/±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 20,000¿ø/°£È£»ç,ÀÓ»ó½É¸®»ç,»çȸº¹Áö»ç 20,000¿ø/Æò»ýȸ¿ø-¸éÁ¦ ÇöÀåµî·Ï-¾øÀ½      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 09:25~09:50 Depression and anxiety during COVID-19  Àå¿ÁÁø(±¹¸³ºÎ°îº´¿ø) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 09:50~10:15 The potential impact of COVID-19 on psychosis  ÃµÀºÁø(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 10:15~10:40 The impact of the COVID-19 pandemic on the mental health of Koreans  Á¤¼º¿ø(°è¸íÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 10:40~10:50 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 11:00~11:25 Psychotic symptoms in dementia  ¼ÛÁ¦Çå(±¹¸³³ªÁÖº´¿ø) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 11:25~11:50 Mood and affective symptoms in dementia  ÀÓÀº¼º(È¿»ç¶ûº´¿ø) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 11:50~12:15 Sleep disturbance in dementia  ¹æ¿µ·Õ(¿ï»êÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 12:15~12:25 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 12:30~13:05 Effectiveness of Switching to Long-acting Injectable Aripiprazole in Patients with Recent-onset and Chronic Schizophrenia  ±è¼º¿Ï(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 13:05~13:40 Improving Outcomes of Bipolar Disorder with Long-acting-Injectable Antipsychotics Treatment: Impact on Patients and Careers  Àå¼¼Çå(±è¿ø¹¬±â³äºÀ»ýº´¿ø) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 13:40~14:05 Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality  À̽ÂÀç(°æºÏÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 14:05~14:30 Effects of drug therapy as an early intervention in psychotic disorders  À̺´´ë(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 14:30~14:55 Mindlink: A stigma-free youth-friendly community-based early-intervention centre in Korea  ±è¼º¿Ï(Àü³²ÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 14:55~15:05 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 15:15~15:40 Glucose Metabolism and Obesity in Bipolar Disorder  ¼ºÇü¸ð(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 15:40~16:05 Molecular Biological Association between Bipolar Disorder and Obesity  ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 16:05~16:30 Development of a new treatment target for bipolar disorder in the mechanism of action of antidiabetic drugs  °­ÇÑ°íÀººñ(±¹¸³³ªÁÖº´¿ø) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 16:30~16:40 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 09:25~09:50 The role of dopamine in the schizophrenia and mood disorder  °­Å¿í(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 09:50~10:15 Serotonergic and noradrenergic systems in depression and anxiety disorder  ÀÌ»ó¿ø(°æºÏÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 10:15~10:40 Update of other neurotransmitters: glutamate, GABA, acetylcholine  Àü¼Ò¿¬(Ãæ³²ÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 10:40~10:50 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 11:00~11:25 The general medical conditions causing psychotic symptom  ±è°æ¿ø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 11:25~11:50 Conditions that affect cognitive function  Àå½ÂÈ£(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 11:50~12:15 The effects of acute and chronic stress  ¼­È­±Ô(ºÎ»êÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 12:15~12:25 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 13:40~14:05 Schizoaffective disorder  À±¼®È£(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 14:05~14:30 Schizophrenia and OCD  À±ÇüÁØ(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 14:30~14:55 Schzophrenia and autism spectrum disorder  ¾çÂù¸ð(¿ø±¤ÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 14:55~15:05 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 15:15~15:40 COVID-19 and psychoimmunology  ¹®Àº¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 15:40~16:05 Safety of psychiatric medications in COVID-19  ÀÌÁ¤¾È(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 16:05~16:30 The effectiveness of telepsychiatry  È«Á¤¿Ï(Àͻ꺴¿ø) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 16:30~16:40 ÁúÀÇ ¹× Åä·Ð  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2022-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Á¦27Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2022-09-03
´ÙÀ½±Û ¸¸¼ºÄáÆϺ´ ¹Ì³×¶ö-»ÀÁúȯ ¿¬±¸È¸ (¿Â¶óÀÎ) 2022 CKD-MBD ¿¬±¸È¸ ¿¬¼ö°­Á (18Â÷) : 2022-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
720 ¼­¿ï 2018 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-08 0 2,098 2018-09-05
719 ÀüºÏ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ 2018 ÀüºÏÁöȸ ÇмúÁý´ãȸ : 2018-09-06 0 2,390 2018-09-05
718 °æ±â ¼øõÇâÀÇ´ë È£Èí±â-¾Ë·¹¸£±â ¿¬¼ö°­Á : 2018-10-31 0 4,948 2018-08-29
717 ¼­¿ï ´ëÇÑ»ýÈ°½À°üº´ÇÐȸ 2018 Ãß°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2018-10-28 0 4,544 2018-08-29
716 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø 2018³â Á¦6ȸ °¡Å縯 °ø¿¬¿¹¼ú ¹ß¼º ½ÉÆ÷Áö¾ö : 2018-10-28 0 2,945 2018-08-29
715 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ °æÃßÁúȯ : 2018-10-27 0 1,733 2018-08-29
714 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø 2018 Asan Forum on Otology-Neurotology : 2018-10-27 0 972 2018-08-29
713 ¼­¿ï ¼­¿ï´ëº´¿ø ´ëÇѳúÁ¹ÁßÇÐȸ 10¿ù º¸¼ö±³À° : 2018-10-27 1 813 2018-08-29
712 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(¾Ë·¯Áö °á¸·¿°) : 2018-10-26 0 704 2018-08-29
711 °æ±â °í·Á´ëÇб³¾È»êº´¿ø ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ : 2018-10-26 0 658 2018-08-29
710 °æ³² °æ»ó´ëÇб³º´¿ø NRP(Neonatal Resuscitation Program) : 2018-10-26 0 691 2018-08-29
709 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö±³À° : 2018-10-26 0 576 2018-08-29
708 ºÎ»ê 2018³â 10Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ ¿µ³²Áöȸ ¿¬¼ö°úÁ¤ : 2018-10-26 0 815 2018-08-29
707 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Asan EES Hands-on dissection course : 2018-10-26 0 1,071 2018-08-29
706 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ(¼ö¸é¹«ÈíÁõÀÇ ¼ö¼úÀû Ä¡·á) : 2018-10-26 0 1,010 2018-08-29
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷